Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1987;75:156-162

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theroux, P.
Right arrow Articles by De Lara, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theroux, P.
Right arrow Articles by De Lara, J.

Circulation, Vol 75, 156-162, Copyright © 1987 by American Heart Association


ARTICLES

Fibrinopeptide A and platelet factor levels in unstable angina pectoris

P Theroux, JG Latour, C Leger-Gauthier and J De Lara

Fibrinopeptide A, platelet factor 4, beta-thromboglobulin, thromboxane B2, and 6-keto-prostaglandin F1 alpha were estimated by radioimmunoassay on venous plasma samples taken within 48 hr of admission from 16 consecutive patients with unstable angina and 15 patients with stable angina matched for clinical variables. The ratio of circulating platelet aggregates, platelet aggregation to increasing concentrations of ADP (0.455 to 1.82 micrograms/ml), and platelet thromboxane B2 production in vitro were also tested. The two groups of patients were statistically similar in terms of sex distribution, age, presence of risk factors, use of medication, extent of coronary artery disease and history of previous myocardial infarction. Mean plasma levels of fibrinopeptide A were 2.7 +/- 0.4 ng/ml (geometric means +/- SEM, range 1.5 to 5.5) in patients with stable angina vs 5.5 +/- 1.8 ng/ml (range 2.4 to 32; p less than .001) in those with unstable angina. In the latter group, after 6 to 8 days, fibrinopeptide A levels decreased to 3.6 +/- 0.5 ng/ml (range 1.5 to 9.3; p less than .04 vs admission). All other variables measured were statistically identical in the two groups. We conclude that plasma fibrinopeptide A levels, as opposed to platelet factors, discriminate between patients with unstable and stable angina, indicating an activation of the coagulation system in unstable angina.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
R. De Paulis, E. Cetrano, M. Moscarelli, G. Ando, F. Bertoldo, R. Scaffa, F. Tomai, and L. Chiariello
Effects of ascending aorta replacement on aortic root dilatation
Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 86 - 89.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
Y. Hasumura, N. Aoki, K. Kawano, M. Homori, A. Maki, Y. Hioki, K. Ishikawa, and H. Yoshino
Platelet-Dependent Thrombin Generation in Patients with Unstable Angina Pectoris
Angiology, December 1, 2001; 52(12): 811 - 818.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al.
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Angiology, March 1, 2001; 52(3): 167 - 174.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Minnema, R. J. G. Peters, R. de Winter, Y. P. T. Lubbers, S. Barzegar, K. A. Bauer, R. D. Rosenberg, C. E. Hack, and H. t. Cate
Activation of Clotting Factors XI and IX in Patients With Acute Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2489 - 2493.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax
Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms)
Circulation, October 12, 1999; 100(15): 1609 - 1615.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Moruzzi, S Sarzi-Braga, M Rossi, and M Contini
Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes
Heart, September 1, 1999; 82(3): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y.-H. Li, J.-K. Teng, W.-C. Tsai, L.-M. Tsai, L.-J. Lin, H.-R. Guo, and J.-H. Chen
Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1543 - 1548.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Linder, J. Oldgren, N. Egberg, L. Grip, G. Larson, A. Siegbahn, and L. Wallentin
The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease
Eur. Heart J., April 1, 1999; 20(7): 506 - 518.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
A. Manten, R. J. de Winter, M. C. Minnema, H. ten Cate, J. G. Lijmer, R. Adams, R. J.G. Peters, and S. J.H. van Deventer
Procoagulant and proinflammatory activity in acute coronary syndromes
Cardiovasc Res, November 1, 1998; 40(2): 389 - 395.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Xiao and P. Theroux
Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
Circulation, January 27, 1998; 97(3): 251 - 256.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Golino, M. Ragni, P. Cirillo, D. D'Andrea, A. Scognamiglio, A. Ravera, C. Buono, M. Ezban, N. Corcione, F. Vigorito, et al.
Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial Thrombosis
Circ. Res., January 23, 1998; 82(1): 39 - 46.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Ito, J. Tanouchi, J. Kato, M. Nishino, K. Iwai, H. Tanahashi, M. Hori, Y. Yamada, T. Kamada, and T. Ito
Prethrombotic State Due to Hypercoagulability in Patients with Permanent Transvenous Pacemakers
Angiology, October 1, 1997; 48(10): 901 - 906.
[Abstract] [PDF]


Home page
CirculationHome page
S. P. Schulman, P. J. Goldschmidt-Clermont, E. J. Topol, R. M. Califf, F. I. Navetta, J. T. Willerson, N. C. Chandra, A. D. Guerci, J. J. Ferguson, R. A. Harrington, et al.
Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina: A Randomized Multicenter Trial
Circulation, November 1, 1996; 94(9): 2083 - 2089.
[Abstract] [Full Text]


Home page
CirculationHome page
J. D. Marmur, S. V. Thiruvikraman, B. S. Fyfe, A. Guha, S. K. Sharma, J. A. Ambrose, J. T. Fallon, Y. Nemerson, and M. B. Taubman
Identification of Active Tissue Factor in Human Coronary Atheroma
Circulation, September 15, 1996; 94(6): 1226 - 1232.
[Abstract] [Full Text]


Home page
CirculationHome page
I. Ott, F.-J. Neumann, M. Gawaz, M. Schmitt, and A. Schomig
Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina
Circulation, September 15, 1996; 94(6): 1239 - 1246.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Cushman, B. M. Psaty, E. Macy, E. G. Bovill, E. S. Cornell, L. H. Kuller, and R. P. Tracy
Correlates of Thrombin Markers in an Elderly Cohort Free of Clinical Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1163 - 1169.
[Abstract] [Full Text]


Home page
CirculationHome page
L. M. Biasucci, G. Liuzzo, G. Caligiuri, G. Quaranta, F. Andreotti, G. Sperti, W. van de Greef, A. G. Rebuzzi, C. Kluft, and A. Maseri
Temporal Relation Between Ischemic Episodes and Activation of the Coagulation System in Unstable Angina
Circulation, June 15, 1996; 93(12): 2121 - 2127.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Ardissino, P. A. Merlini, G. Gamba, P. Barberis, G. Demicheli, S. Testa, E. Colombi, A. Poli, R. Fetiveau, and C. Montemartini
Thrombin Activity and Early Outcome in Unstable Angina Pectoris
Circulation, May 1, 1996; 93(9): 1634 - 1639.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
L. Grip, C. Hellekant, I. Herzfeld, K. Malmberg, B. Svane, A. Szamosi, M. Velander, and L. Ryden
Coronary Angioplasty in Patients with Unstable Angina, with Special Reference to Preceding Treatment with Antithrombin III and Heparin
Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 107 - 115.
[Abstract] [PDF]


Home page
CirculationHome page
D. Pratico and G. A. FitzGerald
Testosterone and Thromboxane : Of Muscles, Mice, and Men
Circulation, June 1, 1995; 91(11): 2694 - 2698.
[Full Text]


Home page
CirculationHome page
H. M. Hoffmeister, M. Jur, H. P. Wendel, W. Heller, and L. Seipel
Alterations of Coagulation and Fibrinolytic and Kallikrein-Kinin Systems in the Acute and Postacute Phases in Patients With Unstable Angina Pectoris
Circulation, May 15, 1995; 91(10): 2520 - 2527.
[Abstract] [Full Text]


Home page
NEJMHome page
S. G. Thompson, J. Kienast, S. D.M. Pyke, F. Haverkate, J. C.W. van de Loo, and The European Concerted Action on Thrombosis and Di
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
N. Engl. J. Med., March 9, 1995; 332(10): 635 - 641.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
W. Koenig, E. Ernst, and A. Matrai
Blood Rheology Associated with Cardiovascular Risk Factors and Chronic Cardiovascular Diseases: Results of an Epidemiologic Cross-sectional Study
Angiology, January 1, 1988; 39(11): 986 - 995.
[Abstract] [PDF]